Objective. Cardiovascular disease (CVD) is a group of diseases affecting cardiac and blood vessels, and the short-axis cardiac magnetic resonance (CMR) images are considered the gold standard for diagnosis and assessment of CVD. In CMR images, accurate segmentation of cardiac structures (e.g, left ventricle) assists in the parametric quantification of cardiac function. However, the dynamic beating of the heart renders the location of the heart with respect to other tissues difficult to resolve, and the myocardium and its surrounding tissues are similar in gray scale. This makes it challenging to accurately segment the cardiac images. Our goal is to develop a more accurate CMR image segmentation approach. Approach. In this work, we propose a regional perception and multi-scale feature fusion network (RMFNet) for CMR image segmentation. We design two regional perception modules, window selection Transformer (WST) module and grid extraction Transformer (GET) module. The WST module introduces a window selection block to adaptively select the window of interest to perceive information, and a windowed Transformer block to enhance global information extraction within each feature window. The WST module enhances the network performance by improving the window of interest. The GET module grids the feature maps to decrease the redundant information in the feature maps and enhances the extraction of latent feature information of the network. The RMFNet further introduces a novel multi-scale feature extraction (MsFE) module to improve the ability to retain detailed information. Main results. The RMFNet is validated with experiments on three cardiac datasets. The results show the RMFNet outperforms other advanced methods in overall performance. The RMFNet is further validated for generalizability on a multi-organ dataset. The results show the RMFNet also surpasses other comparison methods. Significance. Accurate medical image segmentation can reduce the stress of radiologists and play an important role in image-guided clinical procedures.
The characteristics of pulmonary tuberculosis are complex, and the cost of manual screening is high. The detection model based on convolutional neural network is an essential method for assisted diagnosis with artificial intelligence. However, it also has the disadvantages of complex structure and a large number of parameters, and the detection accuracy needs to be further improved. Therefore, an improved lightweight YOLOv4 pulmonary tuberculosis detection model named MIP-MY is proposed. Firstly, over 300 actual cases are selected to make a common dataset by professional physicians, which is used to evaluate the performance of the model. Subsequently, by introducing the inverted residual channel attention and the pyramid pooling module, a new structure of MIP is created and used as the backbone extractor of MIP-MY, which could further decrease the number of parameters and fuse context information. Then the multiple receptive field module is added after the three effective feature layers of the backbone extractor, which effectively enhances the information extraction ability of the deep feature layer and reduces the miss detection rate of small pulmonary tuberculosis lesions. Finally, the pulmonary tuberculosis detection model MIP-MY with lightweight and multiple receptive field characteristics is constructed by combining each improved modules with multiscale structure. Compared to the original YOLOv4, the model parameters of MIP-MY is reduced by 47%, while the mAP value is raised to 95.32% and the miss detection rate is decreased to 6%. It is verified that the model can effectively assist radiologists in the diagnosis of pulmonary tuberculosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.